IL1RN
Interleukin-1 receptor antagonist protein
Also known as: ICIL-1RA, IL-1RN, IL1F3, IL1RA, IL1RA_HUMAN, IRAP, MGC10430
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P18510
- Gene
- IL1RN
- Ensembl
- ENSG00000136689
- Chromosome
- 2
- Canonical length
- 177 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Nucleoplasm,Centrosome,Cytosol
- Secretome location
- Secreted to blood
OverviewNCBI Gene
The protein encoded by this gene is a member of the interleukin 1 cytokine family. This protein inhibits the activities of interleukin 1, alpha (IL1A) and interleukin 1, beta (IL1B), and modulates a variety of interleukin 1 related immune and inflammatory responses, particularly in the acute phase of infection and inflammation. This gene and five other closely related cytokine genes form a gene cluster spanning approximately 400 kb on chromosome 2. A polymorphism of this gene is reported to be associated with increased risk of osteoporotic fractures and gastric cancer. Several alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Aug 2020]
Canonical amino-acid sequenceUniProt
177 residues, UniProt reviewed canonical sequence.
>P18510|IL1RN
1 MEICRGLRSH LITLLLFLFH SETICRPSGR KSSKMQAFRI WDVNQKTFYL RNNQLVAGYL
61 QGPNVNLEEK IDVVPIEPHA LFLGIHGGKM CLSCVKSGDE TRLQLEAVNI TDLSENRKQD
121 KRFAFIRSDS GPTTSFESAA CPGWFLCTAM EADQPVSLTN MPDEGVMVTK FYFQEDELocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL1RN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 1,887 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 1,887 nTPM
- vagina: 441 nTPM
- tonsil: 312 nTPM
- cervix: 312 nTPM
- salivary gland: 243 nTPM
- bone marrow: 221 nTPM
Single-cell type
- esophageal apical cells: 19,454 nCPM
- esophageal suprabasal cells: 3,858 nCPM
- suprabasal keratinocytes: 1,259 nCPM
- neutrophils: 1,122 nCPM
- ocular epithelial cells: 745 nCPM
- esophageal basal cells: 726 nCPM
Immune cell
- neutrophil: 257 nTPM
- classical monocyte: 70 nTPM
- myeloid DC: 67 nTPM
- intermediate monocyte: 29 nTPM
- total PBMC: 22 nTPM
- non-classical monocyte: 15 nTPM
Brain region
- cerebral cortex: 2.2 nTPM
- thalamus: 2.2 nTPM
- choroid plexus: 1.9 nTPM
- pons: 1.2 nTPM
- spinal cord: 1.2 nTPM
- white matter: 0.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IL1RN.
Disease | AllUniProt
Conditions IL1RN is implicated in, by any mechanism.
- Microvascular complications of diabetes 4 (MVCD4) MIM:612628
- Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis (CRMO2) MIM:612852
Disease | GeneticClinVar
13 pathogenic / likely-pathogenic of 252 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Sterile multifocal osteomyelitis with periostitis and pustulosis
- Gastric cancer susceptibility after h. pylori infection
- Microvascular complications of diabetes, susceptibility to, 4
- Interstitial lung disease 2
- Malignant tumor of urinary bladder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.91
- gnomAD pLI
- 0.03
- gnomAD missense Z
- 0.01
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- acute-phase response
- immune response
- inflammatory response
- insulin secretion
- lipid metabolic process
- negative regulation of heterotypic cell-cell adhesion
- negative regulation of interleukin-1-mediated signaling pathway
- response to glucocorticoid
Molecular functions
- cytokine activity
- interleukin-1 receptor antagonist activity
- interleukin-1 receptor binding
- interleukin-1, type I receptor binding
- interleukin-1, type II receptor binding
- interleukin-1 type I receptor antagonist activity
- interleukin-1 type II receptor antagonist activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IL1RN in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL1RN as an antibody target. Whether an autoantibody or antibody against IL1RN could matter depends on whether native IL1RN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL1RN is annotated as secreted, so native IL1RN circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label IL1RN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...